Status:

COMPLETED

Study of Rituximab Plus High-Dose Chemotherapy Non-Hodgkin's Lymphoma

Lead Sponsor:

University of Michigan Rogel Cancer Center

Conditions:

Lymphoma, Non-Hodgkin's

Eligibility:

All Genders

Phase:

PHASE2

Brief Summary

This study is being conducted to determine the safety, side effects, and response to a combination of an established high-dose chemotherapy regimen, plus the addition of Rituximab (which is a form of ...

Detailed Description

Combination chemotherapy is the standard treatment as initial therapy for advanced stage aggressive Non-Hodgkin's lymphoma (NHL). Standard chemotherapy cures less than 40% of patients. When patients r...

Eligibility Criteria

Inclusion

  • Histologically documented, aggressive and/ or intermediate grade and high-grade B cell NHL, CD20 positive.
  • In relapse after primary conventional chemotherapy
  • Tumor sensitive (at least a partial response) to induction chemotherapy and/ or radiation therapy after treatment for relapse
  • Treatment of CNS or meningeal disease (cytology-negative CSF) if present
  • Treatment of CNS or meningeal disease (cytology-negative CSF) if present.
  • Cumulative total doxorubicin dosage \<500 mg/m2
  • Performance score: 0-2
  • Prior malignancies eligible if treated for cure and without active disease
  • Patients must not be pregnant or nursing.
  • Prior Immunotherapy is allowed
  • Signed Informed Consent
  • Absolute neutrophil count \> 1500/ µl, platelet count \>100,000/ µl
  • Bilirubin \<1.5 x normal, SGOT \<2.5 x normal
  • Serum creatinine \<1.5 mg/dl
  • Ejection fraction \> 45% or \> 40% with normal wall motion
  • HIV negative
  • FEV1, DLCO \> 50% predicted

Exclusion

  • Pregnant or nursing

Key Trial Info

Start Date :

April 1 2001

Trial Type :

INTERVENTIONAL

End Date :

January 1 2007

Estimated Enrollment :

35 Patients enrolled

Trial Details

Trial ID

NCT00143871

Start Date

April 1 2001

End Date

January 1 2007

Last Update

February 1 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The University of Michigan

Ann Arbor, Michigan, United States, 48109